Detalhe da pesquisa
1.
Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response.
J Infect Dis
; 226(10): 1717-1720, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723970
2.
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients.
Vaccine
; 41(52): 7663-7670, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007341
3.
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.
Nat Commun
; 14(1): 4551, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507392
4.
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina.
Front Immunol
; 13: 992370, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225925
5.
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.
EBioMedicine
; 83: 104230, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988465
6.
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Cell Rep Med
; 3(8): 100706, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926505
7.
Antibody durability at 1 year after Sputnik V vaccination.
Lancet Infect Dis
; 22(5): 589-590, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305316
8.
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people.
Lancet Infect Dis
; 22(8): 1118-1119, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777383